CD14: a bridge between innate immunity and adaptive IgE responses

Area of Science:

• Immunology
• Genetics

Background:

• Total IgE levels are genetically controlled, with chromosome 5q implicated in asthma and bronchial hyperresponsiveness.
• CD14, a myeloid pattern recognition receptor, is crucial for innate immune responses to bacterial ligands.

Purpose of the Study:

• To investigate the association between genetic variations in the CD14 gene promoter and total IgE levels.
• To analyze the relationship between CD14 haplotypes, total IgE, and soluble CD14 (sCD14) levels.

Main Methods:

• Systematic analysis of five single nucleotide polymorphisms in the CD14 promoter.
• Genotyping of CD14 haplotypes in 390 individuals from the Children Respiratory Study.
• Measurement of serum total IgE and soluble CD14 levels.

Main Results:

• A strong inverse correlation was observed between CD14 haplotypes and serum levels of total IgE and sCD14.
• Individuals with the -1359T/-1145A/-159C CD14 haplotype exhibited the highest IgE and lowest sCD14 levels.
• Conversely, carriers of the -1359G/-1145G/-159T haplotype showed the lowest IgE and highest sCD14 levels.

Conclusions:

• Genetic variations in the CD14 gene may modulate the impact of bacterial ligand exposure on T-helper 2 (Th2) responses.
• CD14 genetic polymorphisms are linked to differential regulation of IgE and sCD14 levels, influencing immune responses.